Compare WI AB 502 (2024) and WI SB 405 (2026)
The introduced text of these two bills, side by side, with the wording they share.
- WI AB 502 (2024) · Wisconsin · 2024 · Failed
- WI SB 405 (2026) · Wisconsin · 2026 · Vetoed
857 shared 8-word phrases found in the introduced text of these two bills.
This highlights wording the two bills share in their introduced text. A shared passage may include text that both bills quote from the same existing law, not only language either one drafted. A match shows that the texts overlap; it does not show who drafted a bill, and filing order alone does not show which bill copied which.
| WI AB 502 (2024) | WI SB 405 (2026) |
|---|---|
| AN ACT to create 895.039 of the statutes; relating to: a civil cause of action for a minor injured by a gender transition procedure. Analysis by the Legislative Reference Bureau This bill establishes a civil cause of action against a health care provider who performs a gender transition procedure, as defined in the bill, on an individual who is under 18 years of age and who is injured, including any physical, psychological, emotional, or physiological injury, by the gender transition procedure or related treatment or the aftereffects of the gender transition procedure or related treatment. Under the bill, such an action must be commenced before the individual attains the age of 33 years. Th… | AN ACT to create 895.039 of the statutes; relating to: a civil cause of action for a minor injured by a gender transition procedure. Analysis by the Legislative Reference Bureau This bill establishes a civil cause of action against a health care provider who performs a gender transition procedure, as defined in the bill, on an individual who is under 18 years of age and who is injured, including any physical, psychological, emotional, or physiological injury, by the gender transition procedure or related treatment or the aftereffects of the gender transition procedure or related treatment. Under the bill, such an action must be commenced before the individual attains the age of 33 years. Th… |
| way to treat the mental health concern. 3. At least | way to treat the mental health concern. 3. At least |
| The health care provider receives the voluntary and informed consent of the | The health care provider receives the voluntary and informed consent of the |
| at least 30 days before the first treatment of the gender transition procedure and during every subsequent medical visit for treatment during the following | at least 30 days before the first treatment of the gender transition procedure and during every subsequent medical visit for treatment during the following |
| medical visit for treatment during the following 6 months, the minor and the minor's parent or legal guardian is provided with the following notice, both orally and in writing in at least 14-point type in a proportional font | medical visit for treatment during the following 6 months, the minor and the minor[s parent or legal guardian is provided with the following notice, both orally and in writing in at least 14-point type in a proportional font |
| NOTICE If your child begins one of these treatments, it may actually worsen the discordance and thus increase the likelihood that your child will need additional and more serious interventions to address the worsening condition. For example, if your child begins socially transitioning or taking puberty blockers, that treatment may significantly increase the likelihood that your child's discordance will worsen and lead to your child eventually seeking cross-sex hormones or even surgery to remove some of your child's body parts. Sweden, Finland, and the United Kingdom have conducted systematic reviews of evidence and concluded that there is no evidence that the potential benefits of | NOTICE If your child begins one of these treatments, it may actually worsen the discordance and thus increase the likelihood that your child will need additional and more serious interventions to address the worsening condition. For example, if your child begins socially transitioning or taking puberty blockers, that treatment may significantly increase the likelihood that your child[s discordance will worsen and lead to your child eventually seeking cross-sex hormones or even surgery to remove some of your child[s body parts. Sweden, Finland, and the United Kingdom have conducted systematic reviews of evidence and concluded that there is no evidence that the potential benefits of |
| puberty blockers and cross-sex hormones for this purpose outweigh the known or assumed risks. Medical authorities in Sweden, Finland, and the United Kingdom have since recommended psychotherapy as the first line of treatment for youth gender dysphoria, with drugs and surgeries reserved as a measure of last resort. Medical authorities in France have advised “great caution” when prescribing hormones for gender dysphoria. There are people who underwent gender transition treatments as minors and later regretted that decision and the physical harm that these treatments caused, and the total percentage of people who experience this regret is unknown. Some estimate that the rate is below 2 percent… | puberty blockers and cross-sex hormones for this purpose outweigh the known or assumed risks. Medical authorities in Sweden, Finland, and the United Kingdom have since recommended psychotherapy as the first line of treatment for youth gender dysphoria, with drugs and surgeries reserved as a measure of last resort. Medical authorities in France have advised Xgreat cautionY when prescribing hormones for gender dysphoria. There are people who underwent gender transition treatments as minors and later regretted that decision and the physical harm that these treatments caused, and the total percentage of people who experience this regret is unknown. Some estimate that the rate is below 2 percent… |
| Sometimes gender transition treatments have been proposed as a way to reduce the chances of a minor committing suicide due to discordance between the minor's sex and his or her perception, but the rates of actual suicide from this discordance remain extremely low. Furthermore, as recognized by health authorities in Europe, there is no evidence that suicidality is caused by “unaffirmed” gender or that gender transition treatments are causally linked to a reduction in serious suicidal attempts or ideations. For puberty blockers: Puberty blockers are not approved for this purpose by the U.S. food and drug administration, which is the federal agency that determines which drugs are safe and effe… | Sometimes gender transition treatments have been proposed as a way to reduce the chances of a minor committing suicide due to discordance between the minor[s sex and his or her perception, but the rates of actual suicide from this discordance remain extremely low. Furthermore, as recognized by health authorities in Europe, there is no evidence that suicidality is caused by XunaffirmedY gender or that gender transition treatments are causally linked to a reduction in serious suicidal attempts or ideations. For puberty blockers: Puberty blockers are not approved for this purpose by the U.S. food and drug administration, which is the federal agency that determines which drugs are safe and effe… |
| puberty is allowed to resume once the patient reaches the appropriate age. Studies on the benefits of using puberty blockers for gender dysphoria are notoriously weak. Puberty blockers are not fully reversible because, among other risks, puberty blockers may intensify a minor's discordance and cause it to persist. Puberty blockers increase the risk of your child being sterilized, meaning that he or she will never be able to have children. Puberty blockers may also cause diminished bone density for your child, increasing the risk of fracture and early osteoporosis. Puberty blockers may also prevent your child from ever being able to engage in sexual activity or achieve orgasm for the rest of… | puberty is allowed to resume once the patient reaches the appropriate age. Studies on the benefits of using puberty blockers for gender dysphoria are notoriously weak. Puberty blockers are not fully reversible because, among other risks, puberty blockers may intensify a minor[s discordance and cause it to persist. Puberty blockers increase the risk of your child being sterilized, meaning that he or she will never be able to have children. Puberty blockers may also cause diminished bone density for your child, increasing the risk of fracture and early osteoporosis. Puberty blockers may also prevent your child from ever being able to engage in sexual activity or achieve orgasm for the rest of… |
| blockers. The full effects of puberty blockers on brain development and cognition are unknown. For cross-sex hormones: The use of cross-sex hormones in males is associated with numerous health risks, such as thromboembolic disease, including blood clots; cholelithiasis, including gallstones; coronary artery disease, including heart attacks; macroprolactinoma, which is a tumor of the pituitary gland; cerebrovascular disease, including stroke; hypertriglyceridemia, which is an elevated level of triglycerides in the blood; breast cancer; and irreversible infertility. The use of cross-sex hormones in females is associated with risks of erythrocytosis, which is an increase in red blood cells; se… | blockers. The full effects of puberty blockers on brain development and cognition are unknown. For cross-sex hormones: The use of cross-sex hormones in males is associated with numerous health risks, such as thromboembolic disease, including blood clots; cholelithiasis, including gallstones; coronary artery disease, including heart attacks; macroprolactinoma, which is a tumor of the pituitary gland; cerebrovascular disease, including stroke; hypertriglyceridemia, which is an elevated level of triglycerides in the blood; breast cancer; and irreversible infertility. The use of cross-sex hormones in females is associated with risks of erythrocytosis, which is an increase in red blood cells; se… |
| For surgical procedures: The dangers, risks, complications, and long-term concerns associated with these types of procedures are almost entirely unknown. There are no long-term studies on either the effectiveness or safety of these surgical procedures. SECTION 2.0Initial applicability | For surgical procedures: The dangers, risks, complications, and long-term concerns associated with these types of procedures are almost entirely unknown. There are no long-term studies on either the effectiveness or safety of these surgical procedures. SECTION 2. Initial applicability |
| This act first applies to a gender transition procedure performed on the effective date of this subsection. (END | This act first applies to a gender transition procedure performed on the effective date of this subsection. (END |